HomeGLPG • AMS
Galapagos NV
€29.58
Mar 28, 6:00:00 PM GMT+1 · EUR · AMS · Disclaimer
StockNL listed security
Previous close
€30.34
Day range
€29.45 - €30.42
Year range
€29.45 - €41.92
Market cap
1.98B EUR
Avg Volume
90.41K
P/E ratio
-
Dividend yield
-
Primary exchange
AMS
In the news
Financials
Income Statement
Revenue
Net income
(EUR)Dec 2023Y/Y change
Revenue
Operating expense
Net income
Net profit margin
Earnings per share
EBITDA
Effective tax rate
Total assets
Total liabilities
(EUR)Dec 2023Y/Y change
Cash and short-term investments
3.68B-10.00%
Total assets
4.36B-7.96%
Total liabilities
1.56B-29.28%
Total equity
2.80B
Shares outstanding
65.95M
Price to book
0.72
Return on assets
Return on capital
Net change in cash
(EUR)Dec 2023Y/Y change
Net income
Cash from operations
Cash from investing
Cash from financing
Net change in cash
Free cash flow
About
Galapagos NV is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
Founded
1999
Website
Employees
1,233
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu